Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Total Non-Current Liabilities (2020 - 2025)

Bio Essence has reported Total Non-Current Liabilities over the past 6 years, most recently at $56156.0 for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $56156.0 for Q4 2025, down 87.45% from a year ago — trailing twelve months through Dec 2025 was $56156.0 (down 87.45% YoY), and the annual figure for FY2025 was $56156.0, down 87.45%.
  • Total Non-Current Liabilities for Q4 2025 was $56156.0 at Bio Essence, down from $56493.0 in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for BIOE hit a ceiling of $3.2 million in Q1 2025 and a floor of $46219.0 in Q4 2023.
  • Median Total Non-Current Liabilities over the past 5 years was $1.3 million (2022), compared with a mean of $1.2 million.
  • Peak annual rise in Total Non-Current Liabilities hit 1453.99% in 2025, while the deepest fall reached 98.16% in 2025.
  • Bio Essence's Total Non-Current Liabilities stood at $1.4 million in 2021, then decreased by 10.47% to $1.2 million in 2022, then plummeted by 96.24% to $46219.0 in 2023, then soared by 868.03% to $447414.0 in 2024, then tumbled by 87.45% to $56156.0 in 2025.
  • The last three reported values for Total Non-Current Liabilities were $56156.0 (Q4 2025), $56493.0 (Q3 2025), and $156344.0 (Q2 2025) per Business Quant data.